why choose us

First received: March 23, 2023

Clinical Trial: A Study to Evaluate the Safety, Tolerability, PK and PD of HNC1058

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: IPF

Study Type: INTERVENTIONAL


Official Title: A Randomized, Double-blind, Placebo-controlled, Single Ascending Doses (SAD) Study Following Oral Administration in Healthy Subjects to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodyn

Brief Summary: The purpose of this First-in-Human study is to evaluate the safety and tolerability after single ascending oral doses of HNC1058 given to healthy subjects, compared to placebo.

Read more